FP
TTOO

Flagship Pioneering’s T2 Biosystems, Inc TTOO Stock Holding History

Flagship Pioneering’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-390
Closed -$8.19M – 6
2017
Q3 		$8.19M Hold
390
– – 2.74% 4
2017
Q2 		$6.26M Hold
390
– – 2.21% 4
2017
Q1 		$10.3M Hold
390
– – 2.73% 6
2016
Q4 		$10.3M Sell
390
-45
-10% -$1.39M 3.34% 6
2016
Q3 		$15.8M Buy
+435
New +$14.3M 4.3% 6

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Flagship Pioneering's TTOO Position: Q4 2017 in Review

Flagship Pioneering sold out of T2 Biosystems, Inc (TTOO) in Q4 2017, closing a stake of 390 shares — an estimated $8.19M sold.

Flagship Pioneering first reported a position in TTOO in Q3 2016 and held it in 5 quarters. The position peaked at $15.8M in Q3 2016. 35 funds tracked by Wall St. Rank hold TTOO as of Q4 2017.

  • Flagship Pioneering reported no remaining T2 Biosystems, Inc position as of Q4 2017 after selling out during the quarter.
  • Flagship Pioneering sold 390 T2 Biosystems, Inc shares in Q4 2017, an estimated $8.19M.
  • Flagship Pioneering first reported a position in T2 Biosystems, Inc in Q3 2016 and held it in 5 quarters.
  • Flagship Pioneering's T2 Biosystems, Inc position peaked at $15.8M in Q3 2016.
  • 35 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2017.

Based on Flagship Pioneering's 13F filing for Q4 2017, filed 14 Feb 2018.